Reframe Cancer
PrivateCompany Overview
Reframe Cancer operates in Healthcare & Life Sciences and is based in the United Kingdom. It was founded in 2012.
Reframe Cancer is a healthcare services company that provides personalized clinical navigation and support for individuals diagnosed with cancer and their carers.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, InsurTech, Telemedicine, HR
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reframe Cancer Comparables
Compare Reframe Cancer with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Check4Cancer | 89% | |
| Perci Health | 85% | |
| Jasper Health | 78% |
For institutional investors. Book with your work email.
Reframe Cancer Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 31% MoM, from 3K to 4K.
- May 2, 2025
Monthly visitors grew 186% MoM, reaching 4K.
For institutional investors. Book with your work email.
Reframe Cancer Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reframe Cancer's valuation, stock price, and market status.
Is Reframe Cancer a public or private company?
Reframe Cancer is a private company.
What is the current stock price of Reframe Cancer?
Reframe Cancer is a private company, so its shares have no public market price. Caplight tracks Reframe Cancer's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reframe Cancer worth (valuation)?
Valuation information for Reframe Cancer is not publicly available.
Can I buy Reframe Cancer stock?
Reframe Cancer shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reframe Cancer's last funding round?
Funding round information for Reframe Cancer is not publicly available.
Who are the main investors in Reframe Cancer?
Investor information for Reframe Cancer is not publicly disclosed.
Will Reframe Cancer IPO soon?
No public IPO plans have been announced for Reframe Cancer.
How can I track Reframe Cancer secondary market activity?
Caplight tracks bids, offers, and trades in Reframe Cancer's shares on secondary markets.